RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study

Documenti analoghi

• Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
  di: Le Calvez-Kelm, Florence, et al.
  Pubblicazione: (2011)
• Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
  di: Damiola, Francesca, et al.
  Pubblicazione: (2014)
• ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry
  di: Renault, Anne-Laure, et al.
  Pubblicazione: (2016)
• Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
  di: Tavtigian, Sean V., et al.
  Pubblicazione: (2009)
• Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2
  di: Nguyen-Dumont, Tú, et al.
  Pubblicazione: (2011)